Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07084519

Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction

Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy Versus Conventional Fractionated Radiotherapy in Breast Cancer Patients Undergoing Prosthetic Breast Reconstruction

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
190 (estimated)
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
Sex
Female
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study investigates the safety and efficacy of hypofractionated radiotherapy (HFRT) versus conventional fractionated radiotherapy (CFRT) in breast cancer patients undergoing total mastectomy with prosthetic reconstruction. Study Design Population: Patients with high-risk breast cancer after mastectomy and immediate implant reconstruction. Intervention: HFRT Arm: 43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks). Control Arm: CFRT (50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks). Endpoints Primary: Reconstruction failure rate (e.g., implant removal, capsular contracture)

Conditions

Interventions

TypeNameDescription
RADIATIONhypofractionated radiotherapy43.5 Gy in 15 fractions (2.9 Gy/fraction, 3 weeks)
RADIATIONconventional fractionated radiotherapy50 Gy in 25 fractions, 2 Gy/fraction, 5 weeks

Timeline

Start date
2025-08-10
Primary completion
2025-12-31
Completion
2030-12-31
First posted
2025-07-24
Last updated
2025-07-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07084519. Inclusion in this directory is not an endorsement.